Generic Name
Pancrelipase
Indications/Uses
Viokase-V is pancreatic enzymes, which assist in digestion in animals suffering from pancreatic insufficiency disorder. A pancreatic enzyme concentrate belonging to porcine origin, Viokase-V acts as a digestive aid in replacement therapy. The drug contains standardized amylase, protease and lipase activities as well as esterases, peptidases, nucleases and elastase. The pancreatic insufficiency disease, also known as 'exocrine pancreatic insufficiency' or 'maldigestion syndrome’, is primarily characterized by a reduction or absence of pancreatic enzymes in the dog. Because of this disorder, the proteins, starches, and fats present in their diet cannot be broken down and assimilated through the intestinal wall. The food particles remain in the gastrointestinal tract and pass out through the feces as undigested materials.
Dosage Information
Viokase-V Tablets are supplied 425 mg each in bottles of 100 and 500. Administer the tablets before each meal. Frequent feeding (at least 3 times a day) is highly important. Each Viokase-V tablet contains enough pancreatic enzymes; 33 g fat, 57 g protein and 64 g starch to digest. The recommended dose of Viokase-V tablets for dogs is 2-3 tablets with each meal. For cats, the general dose is 1/2-1 tablet with each meal. Adjust the dosage of the drug based on the severity of the pancreatic exocrine deficiency and weight of the animal.